Similar articles for PMID: 31414291

Year	Number of Results
1991	1
1997	2
1999	1
2002	1
2003	1
2004	1
2007	1
2008	1
2009	1
2011	1
2012	2
2013	10
2014	10
2015	14
2016	6
2017	14
2018	28
2019	54
2020	49
2021	42
2022	18
2023	9
2024	0

1

Clinical Implications of Conversion Surgery After Induction Therapy for T4b Thoracic Esophageal Squamous Cell Carcinoma.

Miyata H, Sugimura K, Motoori M, Omori T, Yamamoto K, Yanagimoto Y, Shinno N, Yasui M, Takahashi H, Wada H, Ohue M, Yano M. Miyata H, et al. Ann Surg Oncol. 2019 Dec;26(13):4737-4743. doi: 10.1245/s10434-019-07727-8. Epub 2019 Aug 14. Ann Surg Oncol. 2019. PMID: 31414291

2

Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.

Ni W, Yang J, Deng W, Xiao Z, Zhou Z, Zhang H, Chen D, Feng Q, Liang J, Lv J, Wang X, Wang X, Zhang T, Bi N, Deng L, Wang W. Ni W, et al. BMC Cancer. 2020 Feb 22;20(1):144. doi: 10.1186/s12885-020-6622-0. BMC Cancer. 2020. PMID: 32087687 Free PMC article.

3

A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.

Yokota T, Kato K, Hamamoto Y, Tsubosa Y, Ogawa H, Ito Y, Hara H, Ura T, Kojima T, Chin K, Hironaka S, Kii T, Kojima Y, Akutsu Y, Matsushita H, Kawakami K, Mori K, Makiuchi T, Nagumo R, Kitagawa Y. Yokota T, et al. Ann Surg Oncol. 2020 Feb;27(2):460-467. doi: 10.1245/s10434-019-07654-8. Epub 2019 Aug 2. Ann Surg Oncol. 2020. PMID: 31376034 Clinical Trial.

4

A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.

Ni W, Yu S, Zhang W, Xiao Z, Zhou Z, Chen D, Feng Q, Liang J, Lv J, Gao S, Mao Y, Xue Q, Sun K, Liu X, Fang D, Li J, Wang D. Ni W, et al. BMC Cancer. 2020 Feb 18;20(1):130. doi: 10.1186/s12885-020-6592-2. BMC Cancer. 2020. PMID: 32070309 Free PMC article. Clinical Trial.

5

REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.

Sato Y, Motoyama S, Nanjo H, Ito S, Yoshino K, Sasaki T, Kuribayashi K, Nagaki Y, Imai K, Saito H, Minamiya Y, Ogawa J. Sato Y, et al. Ann Surg Oncol. 2013 Sep;20(9):3044-51. doi: 10.1245/s10434-013-2983-9. Epub 2013 May 5. Ann Surg Oncol. 2013. PMID: 23645481

6

Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma.

Kang J, Lee HP, Kim HR, Kim JH, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Ahn JY, Ryu JS, Cho KJ, Lee MY, Kim SB, Kim YH, Park SR. Kang J, et al. Surg Oncol. 2020 Dec;35:491-497. doi: 10.1016/j.suronc.2020.10.015. Epub 2020 Oct 24. Surg Oncol. 2020. PMID: 33130441

7

Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.

Sugawara K, Yagi K, Okumura Y, Nishida M, Aikou S, Yamashita H, Yamashita H, Seto Y. Sugawara K, et al. Int J Clin Oncol. 2020 Apr;25(4):552-560. doi: 10.1007/s10147-019-01590-z. Epub 2019 Dec 11. Int J Clin Oncol. 2020. PMID: 31828451

8

Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?

Zou B, Tu Y, Liao D, Xu Y, Wang J, Huang M, Ren L, Zhu J, Gong Y, Liu Y, Zhou L, Zhou X, Peng F, Lu Y. Zou B, et al. Thorac Cancer. 2020 Mar;11(3):631-639. doi: 10.1111/1759-7714.13307. Epub 2020 Jan 14. Thorac Cancer. 2020. PMID: 31943824 Free PMC article.

9

Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.

Tanaka T, Ueno M, Iizuka T, Hoteya S, Haruta S, Udagawa H. Tanaka T, et al. Dis Esophagus. 2019 Dec 31;32(12):doz023. doi: 10.1093/dote/doz023. Dis Esophagus. 2019. PMID: 30980070

10

Neoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes.

Tian D, Zhang L, Wang Y, Chen L, Zhang KP, Zhou Y, Wen HY, Fu MY. Tian D, et al. Dis Esophagus. 2019 Mar 1;32(3):doy080. doi: 10.1093/dote/doy080. Dis Esophagus. 2019. PMID: 30247659 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

215 results

Results by year